Dario Publishes New Research Demonstrating That Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose
Portfolio Pulse from Benzinga Newsdesk
DarioHealth Corp. (NASDAQ:DRIO) presented new research at the Diabetes Technology Society 2023 Meeting, demonstrating that users of Dario's digital health solutions who increased physical activity maintained reduced blood glucose levels. The study analyzed data from 989 users, showing significant health improvements over four months. Dario's platform integrates clinical and behavioral data to support chronic condition management, including diabetes, blood pressure, and weight, with a focus on whole health.
November 13, 2023 | 1:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DarioHealth's new research could bolster the company's reputation in digital health, potentially leading to increased user engagement and growth in its diabetes management solutions.
The positive results from the new study are likely to enhance the company's credibility and could lead to increased adoption of Dario's digital health solutions. This may result in a positive short-term impact on DRIO's stock as investors may anticipate higher future revenues from greater market penetration.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90